CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.72-0.09 (-1.15%)
At close: 4:00PM EDT
| Previous close | 7.81 |
| Open | 7.80 |
| Bid | 7.52 x 1000 |
| Ask | 7.75 x 900 |
| Day's range | 7.53 - 7.80 |
| 52-week range | 6.25 - 15.44 |
| Volume | 780,997 |
| Avg. volume | 1,046,279 |
| Market cap | 500.136M |
| Beta (5Y monthly) | 0.62 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.71 |
| Earnings date | 24 Feb 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.19 |
- Zacks
CytomX Therapeutics (CTMX) Upgraded to Buy: What Does It Mean for the Stock?
CytomX Therapeutics (CTMX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Moving Average Crossover Alert: CytomX Therapeutics (CTMX)
CytomX Therapeutics (CTMX) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- Motley Fool
CytomX Therapeutics, Inc. (CTMX) Q4 2020 Earnings Call Transcript
CTMX earnings call for the period ending December 31, 2020.
© 2021 Verizon Media. All rights reserved.
